找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Checkpoint Controls and Targets in Cancer Therapy; Zahid H. Siddik Book 2009 Humana Press 2009 BRCA.DNA.cancer.cancer research.cancer ther

[復(fù)制鏈接]
查看: 11312|回復(fù): 54
樓主
發(fā)表于 2025-3-21 19:31:09 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Checkpoint Controls and Targets in Cancer Therapy
編輯Zahid H. Siddik
視頻videohttp://file.papertrans.cn/225/224212/224212.mp4
概述Brings together experts, who are defining the field of checkpoints, and as such represents a unique collection of insightful contributions that will serve as an important resource for both the researc
叢書名稱Cancer Drug Discovery and Development
圖書封面Titlebook: Checkpoint Controls and Targets in Cancer Therapy;  Zahid H. Siddik Book 2009 Humana Press 2009 BRCA.DNA.cancer.cancer research.cancer ther
描述.Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of cancer. This loss may occur through aberration in any single component involved in signal transduction pathways that orchestrate checkpoint regulation, which may manifest through either a failure to activate the checkpoint or a failure to respond to the activated checkpoint. In normal cells, checkpoint pathways are activated when genetic or cellular homeostasis is compromised, and signals are then transduced to re-stabilize homeostasis, and, failing this, to activate the apoptotic machinery to induce a cellular suicidal response. This implies that both survival and cell death pathways are induced following checkpoint activation, and that the final decision is dependant on the net result of integrating the two sets of signals....It is intriguing that checkpoint pathways are also critical in cancer therapy to provide an apoptotic stimulus when cellular damage induced by the therapeutic agent is detected by the sensor system. Therefore, it is not surprising that failure in pro-survival checkpoint resp
出版日期Book 2009
關(guān)鍵詞BRCA; DNA; cancer; cancer research; cancer therapy; cell; cell death; leukemia; lymphoma; ovarian cancer; rese
版次1
doihttps://doi.org/10.1007/978-1-60761-178-3
isbn_softcover978-1-61779-635-7
isbn_ebook978-1-60761-178-3Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightHumana Press 2009
The information of publication is updating

書目名稱Checkpoint Controls and Targets in Cancer Therapy影響因子(影響力)




書目名稱Checkpoint Controls and Targets in Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Checkpoint Controls and Targets in Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Checkpoint Controls and Targets in Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Checkpoint Controls and Targets in Cancer Therapy被引頻次




書目名稱Checkpoint Controls and Targets in Cancer Therapy被引頻次學(xué)科排名




書目名稱Checkpoint Controls and Targets in Cancer Therapy年度引用




書目名稱Checkpoint Controls and Targets in Cancer Therapy年度引用學(xué)科排名




書目名稱Checkpoint Controls and Targets in Cancer Therapy讀者反饋




書目名稱Checkpoint Controls and Targets in Cancer Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:23:47 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:10:51 | 只看該作者
Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response
地板
發(fā)表于 2025-3-22 06:44:46 | 只看該作者
Interplay of 14-3-3 Family of Proteins with DNA Damage-Regulated Molecules in Checkpoint Control
5#
發(fā)表于 2025-3-22 11:29:55 | 只看該作者
6#
發(fā)表于 2025-3-22 16:01:24 | 只看該作者
DNA Damage Response and the Balance Between Cell Survival and Cell Death
7#
發(fā)表于 2025-3-22 19:52:53 | 只看該作者
Dysfunction of the RB Retinoblastoma Gene in Cancer
8#
發(fā)表于 2025-3-22 23:23:22 | 只看該作者
G1 Phase Cyclins in Cancer Development and Progression
9#
發(fā)表于 2025-3-23 01:57:30 | 只看該作者
The BRCA1/2 Pathway Prevents Some Leukemias and Lymphomas in Addition to Breast/Ovarian Cancers: Mal
10#
發(fā)表于 2025-3-23 07:02:17 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 14:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宜黄县| 汕头市| 宝山区| 敖汉旗| 江西省| 海南省| 公安县| 海丰县| 廊坊市| 拉萨市| 喀喇| 天祝| 荥经县| 虎林市| 镇雄县| 海伦市| 揭阳市| 唐海县| 叙永县| 历史| 衡阳县| 化德县| 沈丘县| 镇远县| 马边| 呼伦贝尔市| 潞城市| 萍乡市| 白玉县| 张家川| 门源| 新和县| 武城县| 花垣县| 甘洛县| 甘谷县| 图木舒克市| 广丰县| 贵溪市| 德清县| 于都县|